Indications:
1.1 Monotherapy Epilepsy
TROKENDI XR® is indicated in patients 6 years of age and older as initial monotherapy for partial onset or primary generalized tonic-clonic seizures [see Clinical Studies (14.2)].
1.2 Adjunctive Therapy Epilepsy
TROKENDI XR® is indicated as adjunctive therapy in patients 6 years of age and older with partial onset or primary generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome [see Clinical Studies (14.3)].
1.3 Migraine
TROKENDI XR® is indicated for the prophylaxis of migraine headache in adult patients [see Clinical Studies (14.4)].
|